GB201603571D0 - Markers for skeletal disorders - Google Patents

Markers for skeletal disorders

Info

Publication number
GB201603571D0
GB201603571D0 GBGB1603571.9A GB201603571A GB201603571D0 GB 201603571 D0 GB201603571 D0 GB 201603571D0 GB 201603571 A GB201603571 A GB 201603571A GB 201603571 D0 GB201603571 D0 GB 201603571D0
Authority
GB
United Kingdom
Prior art keywords
markers
skeletal disorders
skeletal
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1603571.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Warwick
Original Assignee
University of Warwick
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Warwick filed Critical University of Warwick
Priority to GBGB1603571.9A priority Critical patent/GB201603571D0/en
Publication of GB201603571D0 publication Critical patent/GB201603571D0/en
Priority to PCT/GB2017/050546 priority patent/WO2017149300A1/fr
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/101—Diffuse connective tissue disease, e.g. Sjögren, Wegener's granulomatosis
    • G01N2800/102—Arthritis; Rheumatoid arthritis, i.e. inflammation of peripheral joints
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/105—Osteoarthritis, e.g. cartilage alteration, hypertrophy of bone
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G01N2800/108—Osteoporosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
GBGB1603571.9A 2016-03-01 2016-03-01 Markers for skeletal disorders Ceased GB201603571D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1603571.9A GB201603571D0 (en) 2016-03-01 2016-03-01 Markers for skeletal disorders
PCT/GB2017/050546 WO2017149300A1 (fr) 2016-03-01 2017-03-01 Marqueurs pour troubles squelettiques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1603571.9A GB201603571D0 (en) 2016-03-01 2016-03-01 Markers for skeletal disorders

Publications (1)

Publication Number Publication Date
GB201603571D0 true GB201603571D0 (en) 2016-04-13

Family

ID=55807143

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1603571.9A Ceased GB201603571D0 (en) 2016-03-01 2016-03-01 Markers for skeletal disorders

Country Status (2)

Country Link
GB (1) GB201603571D0 (fr)
WO (1) WO2017149300A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10837970B2 (en) 2017-09-01 2020-11-17 Venn Biosciences Corporation Identification and use of glycopeptides as biomarkers for diagnosis and treatment monitoring
EP4296262A1 (fr) * 2019-07-12 2023-12-27 Alzchem Trostberg GmbH Procédé de production d'une modification cristalline métastable de l'acide n- (aminoiminométhyl)-2-aminoacétique (iv)
CN112782292B (zh) * 2020-12-21 2023-04-07 浙江大学医学院附属邵逸夫医院 一种代谢物adma在制备早期骨关节炎诊断试剂盒中的应用
WO2024030649A2 (fr) * 2022-08-05 2024-02-08 Ochalski Pawel G Diagnostics et traitements de syndrome articulaire

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050124071A1 (en) * 2003-09-30 2005-06-09 Kraus Virginia B. Methods and compositions for diagnosing musculoskeletal, arthritic and joint disorders by biomarker dating
US20070148704A1 (en) * 2005-10-06 2007-06-28 Ursula Klause Anti-CCPand antinuclear antibodies in diagnosis of rheumatoid arthritis
ES2545688T3 (es) * 2006-09-29 2015-09-15 F. Hoffmann-La Roche Ag Método de evaluación del riesgo de progresión de enfermedad de pacientes con artritis reumatoide
WO2011047358A1 (fr) * 2009-10-15 2011-04-21 Crescendo Bioscience Biomarqueurs et procédés de mesure et de surveillance de l'activité d'une maladie inflammatoire
CA2818328C (fr) * 2012-06-11 2017-09-05 Preventage Healthcare Llc Methodes pour ameliorer la gestion du diabete

Also Published As

Publication number Publication date
WO2017149300A1 (fr) 2017-09-08

Similar Documents

Publication Publication Date Title
DK3478217T3 (en) Historisk scanningsreference for intraorale scanninger
GB201602934D0 (en) Compounds
GB201604027D0 (en) Compounds
GB201604020D0 (en) Compounds
GB201610854D0 (en) Compounds
GB201619694D0 (en) Compounds
GB201620119D0 (en) Compounds
GB201608777D0 (en) Compounds
GB201604022D0 (en) Compounds
GB201604030D0 (en) Compounds
GB201603571D0 (en) Markers for skeletal disorders
GB201613946D0 (en) Compounds
GB201713217D0 (en) Compounds
GB201621520D0 (en) Compounds
GB201604029D0 (en) Compounds
RS63377B1 (sr) Pregradni element za boiseriju
GB201701455D0 (en) Neurodegenerative disorders
GB201622362D0 (en) Compounds
GB201622365D0 (en) Compounds
GB201604031D0 (en) Compounds
GB201407132D0 (en) Marker for neurodegenerative disorders
GB201712443D0 (en) Markers
GB201713179D0 (en) Fixing Marker
GB201720511D0 (en) Compounds
HUP1700151A2 (en) Pavement for horse-races

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)